| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3270240 | HPB | 2009 | 9 Pages |
Abstract
The use of the UCSF Criteria in this cohort increased the number of patients eligible for LTx without compromising 5-year survival rates. Patients whose explant tumours were outside the Milan or UCSF Criteria had poorer outcomes compared with those whose explants remained within these criteria.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
John W.C. Chen, Lilian Kow, Deborah J. Verran, John L. McCall, Stephen Munn, Glenda A. Balderson, Jonathan W. Fawcett, Paul J. Gow, Robert M. Jones, Gary P. Jeffrey, Anthony K. House, Simone I. Strasser,